Latest Breaking News On - Biologics drug substance - Page 1 : comparemela.com

Stocks that will see action: July 24, 2024 - The Hindu BusinessLine

Stocks that will see action: July 24, 2024 - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

United statesAndhra pradeshTamil naduSpandana sphoortyBiocon sdnRao tummalapalliHormosan pharma gmbhSanjivani paranteralEdwardv szoferSwaminathan maniTata steelSofttech engineersConstruction developmentNaukri internet services ltdChennai petroleum corporationInfo edge india ltd

U S FDA Completes Two cGMP Inspections at Biocon Biologics Insulins Facility in Malaysia

U S FDA Completes Two cGMP Inspections at Biocon Biologics Insulins Facility in Malaysia
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Biocon biologicsBiocon sdnDrug administrationBiocon biologic insulins facilityInsulins manufacturing facilityBiologics drug substanceDrug productQuality controlDelivery devicesDrug substancePreventive actionBiocon limited

Strides sells arm s manufacturing unit to Syngene International for Rs 702 crore

Strides Pharma Science has agreed to sell the biologics Unit-3 manufacturing facility of its associate company Stelis Biopharma to Syngene International for INR702 crore ($94m) in cash. Syngene will also invest up to INR100 crore to repurpose and revalidate the Bommasandra Industrial Area in Bengaluru site, which is being repurposed to produce monoclonal antibodies.

Stelis biopharmaSyngene internationalStrides pharma scienceBommasandra industrial areaCovid 19 vaccinesBiologics drug substance